A global player in pMDIs & nasal Drug Delivery Systems, RxPack is a 50:50 JV between Lindal and Coster, who have merged their pharmaceutical businesses setting up a 100% dedicated new pharma company.
Specialized in the development and manufacture of Primary Packaging Devices for the pharmaceutical and generic industries, RxPack is the result of the long-term vision of family-owned entrepreneurship, bringing 60-years’ expertise in the Aerosol & Spray Dispensing platforms.
pMDI valves and actuators: RxPack is your partner of choice. Be it with a single API or combinations with two or more ingredients, RxPack has the right fit according to your inhalation formulations.
RxPack valves come with a dosage range from 25 to 100 µl, are suitable for solutions and suspensions and can be used in combination with actuators having different spray orifice diameters. The excellent sealing and moisture barrier properties make them suitable for use with different types of propellants, including the new generation of green gases, such as HFA 152a.
Full technical and regulatory support completes the offering from the early stages of development through full-scale manufacturing.